Genetic hair loss test to be introduced in Dominican Republic
|
| Published on Wednesday, July 1, 2009 |
Email To Friend Print Version |
IRVINE, USA.-- Men and women in the Dominican Republic will soon have access to genetic tests for predicting the risk of male or female hair loss thanks to a distribution agreement announced on Tuesday by pharmacogenomics research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC.
The genetic baldness tests will be introduced to the Dominican Republic by Skin and Hair Transplant Institute of Santo Domingo. The company is led by Dr Alba Reyes Sagiv, the first surgeon in Latin America to be accepted as “American Board Certified” in the area of hair restoration (ABHRS). She is the Dominican Republic pioneer of the most advanced hair restoration techniques.
“We’re striving to offer the most advanced services and treatments to people suffering from alopecia,” said Sagiv. “The genetic tests made by HairDX have an extremely important role in the detection of future and present AGA in men and women. It gives important information about responsiveness to patients considering Finasteride treatment.”
HairDX’s genetic test provides an accurate and understandable genetic analysis of a man’s or woman’s likelihood of developing androgenetic alopecia, the most common type of hair loss.
“By expanding our global footprint, PharmaGenoma is leading the way in molecular dermatology. We’re pleased to bring the latest in genetic science to men and women in the Dominican Republic,” said Andy Goren, President and CEO of PharmaGenoma. | | | | Reads : 1056 | | | |
|
|
